View Larger Image Current Status of Clinical Trials on FAP Targeted Radiopharmaceuticals Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer Gordon Research Conference-Radionuclide Theranostics for the Management of Cancer – Newry, Maine July 19, 2022 Download the Presentation sofie_c557hm2025-11-03T16:09:18+00:0019, Jul 2022|Presentations| Share This Story, Choose Your Platform! FacebookXLinkedInPinterest Related Posts Addressing Unmet Needs with [18F]FAPI-74 Gallery Addressing Unmet Needs with [18F]FAPI-74 4, Feb 2026 A Target of Opportunity – Shaping the Future of FAPI Gallery A Target of Opportunity – Shaping the Future of FAPI 22, Jun 2025 [68Ga]FAPI-46 Phase 2 clinical development updates Gallery [68Ga]FAPI-46 Phase 2 clinical development updates 9, Jun 2024 Current State of FAP Targeting Radioligands Gallery Current State of FAP Targeting Radioligands 30, May 2024 Current State of FAP Targeting Radioligands Gallery Current State of FAP Targeting Radioligands 30, May 2024
![Addressing Unmet Needs with [18F]FAPI-74](https://sofie.com/wp-content/uploads/2026/02/FAPI-500x383.jpg)
![[68Ga]FAPI-46 Phase 2 clinical development updates](https://sofie.com/wp-content/uploads/2024/06/FAPI-46-Phase-2-clinical-development-updates-500x383.png)
